169 related articles for article (PubMed ID: 37424805)
1. ELL associated factor 2 is a potential diagnostic and prognostic indicator: evidence from the in silico and in vitro experiments.
Yu X; Teng JQ; Chen J; Peng C; Guo TR; Dong MW; Hao XL; Li KX; Huo XX; Ren CC
Am J Cancer Res; 2023; 13(6):2572-2587. PubMed ID: 37424805
[TBL] [Abstract][Full Text] [Related]
2. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
[TBL] [Abstract][Full Text] [Related]
3. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.
Hameed Y
J Cancer Res Ther; 2023 Oct; 19(7):1852-1864. PubMed ID: 38376289
[TBL] [Abstract][Full Text] [Related]
4. A pan-cancer analysis of GINS complex subunit 4 to identify its potential role as a biomarker in multiple human cancers.
Usman M; Okla MK; Asif HM; AbdElgayed G; Muccee F; Ghazanfar S; Ahmad M; Iqbal MJ; Sahar AM; Khaliq G; Shoaib R; Zaheer H; Hameed Y
Am J Cancer Res; 2022; 12(3):986-1008. PubMed ID: 35411239
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of GINS1 highlighted a good diagnostic and prognostic potential of survival in three different subtypes of human cancer.
Ahmad M; Hameed Y; Khan M; Usman M; Rehman A; Abid U; Asif R; Ahmed H; Hussain MS; Rehman JU; Asif HM; Arshad R; Atif M; Hadi A; Sarfraz U; Khurshid U
Braz J Biol; 2021; 84():e250575. PubMed ID: 34852135
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the oncogenic importance and exploring gene-immune cells correlation of ACTB in human cancers.
Li G; Samuel S; Ul Haq SE; Mubarak AS; Studenik CR; Islam A; Aufy M; Kadham MJ; Al-Azzawi AKJ; Abdel-Maksoud MA
Am J Cancer Res; 2023; 13(3):758-777. PubMed ID: 37034229
[TBL] [Abstract][Full Text] [Related]
7. Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer.
Sial N; Saeed S; Ahmad M; Hameed Y; Rehman A; Abbas M; Asif R; Ahmed H; Hussain MS; Rehman JU; Atif M; Khan MR
Int J Gen Med; 2021; 14():7025-7042. PubMed ID: 34707394
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
Han X; Long W; Liu Y; Xu J
Front Surg; 2022; 9():985034. PubMed ID: 36338652
[TBL] [Abstract][Full Text] [Related]
9. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy.
Yang Q; Zeng S; Liu W
PeerJ; 2023; 11():e15019. PubMed ID: 36949759
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers.
Sial N; Rehman JU; Saeed S; Ahmad M; Hameed Y; Atif M; Rehman A; Asif R; Ahmed H; Hussain MS; Khan MR; Ambreen A; Ambreen A
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908119
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic biomarker:
Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics, RNA sequencing, and targeted bisulfite sequencing analyses identify the role of PROM2 as a diagnostic and prognostic biomarker.
Uqaili AA; Usman G; Bhatti U; Nasir H; Zia R; Akram MA; Jawad FA; Farid A; AbdelGawwad MR; Almutairi SM; Elshikh MS; Hussain S; Rasheed RA
Am J Transl Res; 2023; 15(8):5389-5407. PubMed ID: 37692961
[TBL] [Abstract][Full Text] [Related]
13. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
14. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
15.
Tan Z; Chen M; Peng F; Yang P; Peng Z; Zhang Z; Li X; Zhu X; Zhang L; Zhao Y; Liu Y
Transl Cancer Res; 2022 Aug; 11(8):2713-2732. PubMed ID: 36093522
[TBL] [Abstract][Full Text] [Related]
16. Investigating novel biomarkers in uterine corpus endometrial carcinoma: in silico analysis and clinical specimens validation via RT-qPCR and immunohistochemistry.
Li J; Ramzan F; Zhong G
Am J Cancer Res; 2023; 13(9):4376-4400. PubMed ID: 37818076
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer analysis of pituitary tumor-transforming 3, pseudogene.
Li J; Shaikh SN; Uqaili AA; Nasir H; Zia R; Akram MA; Jawad FA; Sohail S; AbdelGawwad MR; Almutairi SM; Elshikh MS; Jamil M; Rasheed RA
Am J Transl Res; 2023; 15(8):5408-5424. PubMed ID: 37692950
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
19. Decoding signal transducer and activator of transcription 1 across various cancers through data mining and integrative analysis.
Munir H; Rana AT; Faheem M; Almutairi SM; Siddique T; Asghar S; Abdel-Maksoud MA; Mubarak A; Elkhamisy FAA; Studenik CR; Yaz H
Am J Transl Res; 2022; 14(6):3638-3657. PubMed ID: 35836889
[TBL] [Abstract][Full Text] [Related]
20. SEC24D gene as a biomarker in human cancers and its association with CD8+ T cell immune cell infiltration.
Sarwar S; Ashraf S; Shafiq M; Malik A; Akhtar S; Arshad R; Jamil M; Gul H; Ullah N
Am J Transl Res; 2023; 15(5):3115-3130. PubMed ID: 37303662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]